Healthcare Wrap: Biotech Surges as Noxopharm, Acrux and TruScreen Lead Week 22

• Noxopharm, Acrux and TruScreen topped the board after fresh data, a licensing deal and funding support.
• Neuren, Fisher & Paykel Healthcare and Aroa Biosurgery paired growth updates with stronger balance sheets.
• Several smaller names raised cash to fund trials, manufacturing and commercial rollouts.
• Some gap-up moves held through the week, while others gave back early gains as traders took profit.